Literature DB >> 3551828

Roxithromycin (RU 965): effective therapy for experimental syphilis infection in rabbits.

S A Lukehart, S A Baker-Zander.   

Abstract

Roxithromycin (RU 965), a new macrolide antibiotic, was shown to be effective for therapy of active syphilis in rabbits. Dark-field-positive lesions were produced in adult male rabbits by intradermal inoculation of approximately 10(6) Treponema pallidum organisms at each of 11 sites. Beginning 7 days after infection, six animals per group were treated with benzathine penicillin G (200,000 U, intramuscularly, weekly for 2 weeks) or roxithromycin (15 mg/kg of body weight, orally, twice daily for 15 days); six animals were not treated. Chancres in untreated animals were dark-field positive throughout the 16-day observation period; all benzathine penicillin-treated rabbits were dark-field negative 1 day after the initiation of therapy. Five of six animals treated with roxithromycin were dark-field negative on day 3 following the initiation of therapy; the sixth animal was dark-field negative by day 6. Lesions in untreated animals reached a mean (+/- standard deviation) maximum diameter of 14.7 +/- 1.91 mm compared with 8.4 +/- 3.6 mm for benzathine penicillin-treated (P less than 0.005) and 10.4 +/- 1.2 mm for roxithromycin-treated (P less than 0.001) animals. Ulceration occurred at 62 of 66 lesions in untreated animals compared with 0 of 66 lesions in each treated group. At 3, 6, and 12 weeks postinfection, Venereal Disease Research Laboratory antibody titers were significantly higher (P less than 0.05) in untreated than in treated animals. Titers in penicillin-treated versus roxithromycin-treated animals were significantly different at 6 weeks postinfection but not at 3 and 12 weeks postinfection. Transfer of tissue from treated rabbits to seronegative recipient animals did not reveal any evidence of persistent infection in the benzathine penicillin- or roxithromycin-treated animals. These findings indicate that benzathine penicillin and roxithromycin, at the doses indicated above, are effective in treating active syphilis in rabbit model.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3551828      PMCID: PMC174689          DOI: 10.1128/AAC.31.2.187

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  EFFECT OF ACTINOSPECTACIN IN EXPERIMENTAL SYPHILIS IN THE RABBIT. I. EARLY LESION SYPHILIS.

Authors:  J W CLARK; A R YOBS
Journal:  Br J Vener Dis       Date:  1963-09

2.  Treatment of primary syphilis.

Authors:  W C Elliott
Journal:  J Am Vener Dis Assoc       Date:  1976-12

3.  Treatment for early syphilis and reactivity of serologic tests.

Authors:  A L Schroeter; J B Lucas; E V Price; V H Falcone
Journal:  JAMA       Date:  1972-07-31       Impact factor: 56.272

4.  Treatment of secondary syphilis.

Authors:  S T Brown
Journal:  J Am Vener Dis Assoc       Date:  1976-12

5.  Treatment of syphilis in pregnancy.

Authors:  S E Thompson
Journal:  J Am Vener Dis Assoc       Date:  1976-12

6.  Cephaloridine treatment of experimental rabbit syphilis.

Authors:  S Kuwahara; H Zenyoji
Journal:  Postgrad Med J       Date:  1967-08       Impact factor: 2.401

7.  Efficacy of aztreonam in treatment of experimental syphilis in rabbits.

Authors:  S A Lukehart; S A Baker-Zander; K K Holmes
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

8.  Erythromycin failure in the treatment of syphilis in a pregnant woman.

Authors:  P Hashisaki; G G Wertzberger; G L Conrad; C R Nichols
Journal:  Sex Transm Dis       Date:  1983 Jan-Mar       Impact factor: 2.830

9.  Characterization of lymphocyte responsiveness in early experimental syphilis. I. In vitro response to mitogens and Treponema pallidum antigens.

Authors:  S A Lukehart; S A Baker-Zander; S Sell
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

10.  Evaluation of rosaramicin phosphate in treatment of experimental syphilis in rabbits.

Authors:  R E Baughn; D M Musher; C B Adams; J M Knox
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

View more
  9 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  A Nonhuman Primate Model for Rectally Transmitted Syphilis.

Authors:  Cassandra Tansey; Chunxia Zhao; Andre Hopkins; Jana M Ritter; Yetunde F Fakile; Allan Pillay; Samantha S Katz; Lara Pereira; James Mitchell; Frank Deyounks; Ellen N Kersh; Janet M McNicholl; Sundaram Ajay Vishwanathan
Journal:  J Infect Dis       Date:  2018-03-13       Impact factor: 5.226

3.  Clarithromycin therapy of experimental Treponema pallidum infections in hamsters.

Authors:  J Alder; K Jarvis; M Mitten; N L Shipkowitz; P Gupta; J Clement
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

4.  In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum.

Authors:  L V Stamm; J T Stapleton; P J Bassford
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

Review 5.  Rabbit Models for Studying Human Infectious Diseases.

Authors:  Xuwen Peng; John A Knouse; Krista M Hernon
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

6.  Efficacy of cefmetazole in the treatment of active syphilis in the rabbit model.

Authors:  S A Baker-Zander; S A Lukehart
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 7.  Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  R A Young; J P Gonzalez; E M Sorkin
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

Review 8.  Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

9.  Successful isolation of Treponema pallidum strains from patients' cryopreserved ulcer exudate using the rabbit model.

Authors:  Lara E Pereira; Samantha S Katz; Yongcheng Sun; Patrick Mills; Willie Taylor; Patricia Atkins; Charles M Thurlow; Kai-Hua Chi; Damien Danavall; Nicholas Cook; Tamanna Ahmed; Alyssa Debra; Susan Philip; Stephanie Cohen; Kimberly A Workowski; Ellen Kersh; Yetunde Fakile; Cheng Y Chen; Allan Pillay
Journal:  PLoS One       Date:  2020-01-13       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.